Munich - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.MU)
12.82
+0.09
+(0.75%)
At close: May 12 at 8:01:43 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 17 | 16 |
| Avg. Estimate | 6.04M | 4.78M | 20.97M | 114.79M |
| Low Estimate | -- | -- | -- | 9.56M |
| High Estimate | 50M | 34.55M | 138.2M | 284.12M |
| Year Ago Sales | -- | -- | -- | 20.97M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 447.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4DN.MU | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 5/8/2025 |
| Maintains | Wedbush: Outperform to Outperform | 5/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/7/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
| Reiterates | B. Riley Securities: Buy to Buy | 3/5/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/3/2025 |